AIKI
AIkido Pharma Inc
Halal Rating :
Last Price
$1.13
Last updated:
Market Cap
-
7D Change
8.65%
1 Year Change
-46.45%
Company Overview
Exchange
Next Earnings Date
AIkido Pharma Inc is a biotechnology company focused on developing small-molecule anti-cancer therapeutics. The company's strategy involves acquiring and developing a diversified portfolio of early-stage technologies, with a particular focus on novel oncology drugs and treatments. They operate through licensing agreements and partnerships with various research institutions.
Use of Interest
Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
Sept. 30, 2024 | $4.04m | $7.24m | - | - | 0.00% | 0.00% |
June 30, 2024 | $6.17m | $8.91m | - | - | 0.00% | 0.00% |
March 31, 2024 | $1.37m | $4.17m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate AIkido Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.